New Zealand markets closed

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
87.75+0.79 (+0.91%)
At close: 04:00PM EDT
87.75 0.00 (0.00%)
After hours: 05:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
1,402,400
1,402,400
1,521,900
1,503,100
823,400
Depreciation & amortisation
144,900
144,900
139,600
134,800
107,200
Deferred income taxes
-272,100
-272,100
-254,500
-41,400
-49,400
Stock-based compensation
139,400
139,400
126,800
109,300
92,600
Change in working capital
-526,300
-526,300
-421,400
145,300
42,200
Inventory
-289,000
-289,000
-213,400
19,000
-120,600
Accounts payable
146,000
146,000
-21,400
195,200
-84,500
Other working capital
629,500
629,500
953,400
1,402,300
647,000
Other non-cash items
10,400
10,400
-800
-86,200
59,500
Net cash provided by operating activities
895,800
895,800
1,218,200
1,732,100
1,054,300
Cash flows from investing activities
Investments in property, plant and equipment
-266,300
-266,300
-264,800
-329,800
-407,300
Acquisitions, net
-95,200
-95,200
0
0
0
Purchases of investments
-105,500
-105,500
-778,900
-1,892,400
-861,700
Sales/maturities of investments
715,800
715,800
1,359,100
529,200
777,000
Other investing activities
-75,000
-75,000
-63,100
-29,500
-39,100
Net cash used for investing activities
173,800
173,800
252,300
-1,722,500
-531,100
Cash flows from financing activities
Debt repayment
-300
-300
-200
-7,000
-17,000
Common stock repurchased
-879,600
-879,600
-1,727,100
-512,800
-625,400
Other financing activities
-1,000
-1,000
-3,600
-300
-1,200
Net cash used provided by (used for) financing activities
-711,000
-711,000
-1,584,500
-356,300
-486,900
Net change in cash
375,400
375,400
-94,800
-332,800
15,800
Cash at beginning of period
772,600
772,600
867,400
1,200,200
1,184,400
Cash at end of period
1,148,000
1,148,000
772,600
867,400
1,200,200
Free cash flow
Operating cash flow
895,800
895,800
1,218,200
1,732,100
1,054,300
Capital expenditure
-266,300
-266,300
-264,800
-329,800
-407,300
Free cash flow
629,500
629,500
953,400
1,402,300
647,000